Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate

Brain and Development

Volumn 29, Issue 7, 2007, Pages 450-453

  Kuhn, J ^a   Bewermeyer, H ^b   Miyajima, H ^c   Takahashi, Y ^c   Kuhn, K F ^d   Hoogenraad, T U ^e  

^a UNIVERSITY OF COLOGNE   (Germany)

^b KRANKENHAUS MERHEIM   (Germany)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Aceruloplasminemia; Heterozygous mutation; Neurodegeneration; Zinc sulphate

Indexed keywords

ZINC SULFATE;

ACERULOPLASMINEMIA; ADOLESCENT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CEREBELLUM DISEASE; DEGENERATIVE DISEASE; DRUG DOSE INCREASE; EXTRAPYRAMIDAL SYNDROME; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; IRON OVERLOAD; LOADING DRUG DOSE; MOTOR DYSFUNCTION; SYMPTOM;

ADMINISTRATION, ORAL; ADOLESCENT; BRAIN; CERULOPLASMIN; FEMALE; HUMANS; IRON OVERLOAD; MUTATION; NEURODEGENERATIVE DISEASES; POSITRON-EMISSION TOMOGRAPHY; ZINC SULFATE;

EID: 34248592679     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2007.01.001     Document Type: Article

References (9)

1. Miyajima H., Kono S., Takahashi Y., Sugimoto M., Sakamoto M., and Sakai N. Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology 57 (2001) 2205-2210
2. Kuhn J., Miyajima H., Takahashi Y., et al. Extrapyramidal and cerebellar movement disorder in association with heterozygous ceruloplasmin gene mutation. J Neurol 252 (2005) 111-113
3. Miyajima H., Takahashi Y., Kamata T., Shimizu H., Sakai N., and Gitlin J.D. Use of desferrioxamine in the treatment of aceruloplasminemia. Ann Neurol 41 (1997) 404-407
4. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
5. Harris Z.L., Durley A.P., Man T.K., and Gitlin J.D. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA 96 (1999) 10812-10817
6. Powell S.R. The antioxidant properties of zinc. J Nutr 130 (2000) 1447S-1454S
7. Donangelo C.M., Woodhouse L.R., King S.M., Viteri F.E., and King J.C. Supplemental zinc lowers measures of iron status in young women with low iron reserves. J Nutr 132 (2002) 1860-1864
8. Ebadi M., Leuschen M.P., el Refaey H., Hamada F.M., and Rojas P. The antioxidant properties of zinc and metallothionein. Neurochem Int 29 (1996) 159-166
9. Hoogenraad T.U. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev 28 (2006) 141-146